B1S Stock Overview
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
YSB Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.91 |
| 52 Week High | HK$0.98 |
| 52 Week Low | HK$0.91 |
| Beta | 0 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -6.84% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| B1S | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -6.8% | -2.7% | 0.9% |
| 1Y | n/a | 1.4% | 4.2% |
Return vs Industry: Insufficient data to determine how B1S performed against the German Healthcare industry.
Return vs Market: Insufficient data to determine how B1S performed against the German Market.
Price Volatility
| B1S volatility | |
|---|---|
| B1S Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.5% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: B1S has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine B1S's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 6,306 | Buzhen Zhang | www.ysbang.cn |
YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company develops ClouDiagnos for diagnostic testing service; wePharmacy, a 24-hour access smart unmanned pharmaceutical booth that connects buyers and the end customers with pharmacist services; SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. It also engages in the wholesale and retail of pharmaceutical and healthcare products.
YSB Inc. Fundamentals Summary
| B1S fundamental statistics | |
|---|---|
| Market cap | €606.49m |
| Earnings (TTM) | -€409.74m |
| Revenue (TTM) | €2.18b |
0.3x
P/S Ratio-1.5x
P/E RatioIs B1S overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| B1S income statement (TTM) | |
|---|---|
| Revenue | CN¥16.97b |
| Cost of Revenue | CN¥15.23b |
| Gross Profit | CN¥1.74b |
| Other Expenses | CN¥4.93b |
| Earnings | -CN¥3.19b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.98 |
| Gross Margin | 10.26% |
| Net Profit Margin | -18.79% |
| Debt/Equity Ratio | 3.1% |
How did B1S perform over the long term?
See historical performance and comparison